These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1075 related items for PubMed ID: 29630517
1. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S. Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517 [Abstract] [Full Text] [Related]
2. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway. Xiao X, Li L, Cui JC, Wang Y. Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973 [Abstract] [Full Text] [Related]
3. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. Wang X, Lu X, Geng Z, Yang G, Shi Y. J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866 [Abstract] [Full Text] [Related]
4. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q, Liu Y, Fan Y, Liu Z, Wang X, Jia M, Geng Z, Zhang J, Lu X. Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [Abstract] [Full Text] [Related]
5. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway. Yang M, Huang S, Zhao Y, Xie B, Hu X, Cai Y. Biochem Biophys Res Commun; 2023 May 07; 655():104-109. PubMed ID: 36934585 [Abstract] [Full Text] [Related]
6. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Zhang Z, Li SY, Zhang LB. Eur Rev Med Pharmacol Sci; 2018 Apr 07; 22(7):1979-1986. PubMed ID: 29687852 [Abstract] [Full Text] [Related]
7. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway. Lv P, Xue Y. Bioengineered; 2021 Dec 07; 12(1):3873-3885. PubMed ID: 34281460 [Abstract] [Full Text] [Related]
8. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells. Cui M, Chang Y, Du W, Liu S, Qi J, Luo R, Luo S. Med Sci Monit; 2018 Jul 25; 24():5152-5158. PubMed ID: 30042377 [Abstract] [Full Text] [Related]
9. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway. Xia S, Ji R, Zhan W. BMC Neurol; 2017 Feb 10; 17(1):30. PubMed ID: 28187755 [Abstract] [Full Text] [Related]
10. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway. Liu ZB, Tang C, Jin X, Liu SH, Pi W. Cancer Biomark; 2018 Feb 10; 23(4):603-613. PubMed ID: 30452404 [Abstract] [Full Text] [Related]
11. Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p. Feng X, Dong X, Wu D, Zhao H, Xu C, Li H. Histol Histopathol; 2020 Feb 10; 35(2):217-224. PubMed ID: 31355416 [Abstract] [Full Text] [Related]
12. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway. Xia F, Chen Y, Jiang B, Du X, Peng Y, Wang W, Huang W, Feng T, Li X. Cell Physiol Biochem; 2018 Feb 10; 50(5):1659-1672. PubMed ID: 30384358 [Abstract] [Full Text] [Related]
13. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. Ma J, Huang X, Li Z, Shen Y, Lai J, Su Q, Zhao J, Xu J. J Cell Physiol; 2019 Aug 10; 234(10):17739-17748. PubMed ID: 30793770 [Abstract] [Full Text] [Related]
14. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway. Lu HW, Liu XD. Eur Rev Med Pharmacol Sci; 2018 Sep 10; 22(17):5576-5582. PubMed ID: 30229831 [Abstract] [Full Text] [Related]
15. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH. Oncotarget; 2017 Jan 03; 8(1):238-247. PubMed ID: 27462868 [Abstract] [Full Text] [Related]
16. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY. Biomed Pharmacother; 2018 Aug 03; 104():686-698. PubMed ID: 29803929 [Abstract] [Full Text] [Related]
17. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Qiu W, Yang Z, Fan Y, Zheng Q. Tumour Biol; 2016 Sep 03; 37(9):12665-12672. PubMed ID: 27448298 [Abstract] [Full Text] [Related]
18. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Lou KX, Li ZH, Wang P, Liu Z, Chen Y, Wang XL, Cui HX. Eur Rev Med Pharmacol Sci; 2018 Mar 03; 22(5):1358-1365. PubMed ID: 29565494 [Abstract] [Full Text] [Related]
19. LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt/β-catenin pathway. Liu P, Wang J, Du W, Chen L. Adv Clin Exp Med; 2023 Sep 03; 32(9):1017-1027. PubMed ID: 36994689 [Abstract] [Full Text] [Related]